These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27448809)

  • 1. Dynamic contrast-enhanced MRI for the assessment of spinal tumor vascularity: correlation with angiography.
    Meng XX; Zhang YQ; Liao HQ; Liu HC; Jiang HL; Ke SJ; Dong WH
    Eur Spine J; 2016 Dec; 25(12):3952-3961. PubMed ID: 27448809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
    Yuan Y; Kuai XP; Chen XS; Tao XF
    Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance perfusion compared with digital subtraction angiography for the evaluation of extradural spinal metastases: a pilot study.
    Mazura JC; Karimi S; Pauliah M; Banihashemi MA; Gobin YP; Bilsky MH; Patsalides A
    Spine (Phila Pa 1976); 2014 Jul; 39(16):E950-4. PubMed ID: 24827525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing hypervascular and hypovascular metastases and normal bone marrow of the spine using dynamic contrast-enhanced MR imaging.
    Khadem NR; Karimi S; Peck KK; Yamada Y; Lis E; Lyo J; Bilsky M; Vargas HA; Holodny AI
    AJNR Am J Neuroradiol; 2012 Dec; 33(11):2178-85. PubMed ID: 22555585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.
    Sato KT; Omary RA; Takehana C; Ibrahim S; Lewandowski RJ; Ryu RK; Salem R
    J Vasc Interv Radiol; 2009 Dec; 20(12):1564-9. PubMed ID: 19846320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of dynamic contrast-enhanced MRI for thyroid tumors.
    Yuan Y; Yue XH; Tao XF
    Eur J Radiol; 2012 Nov; 81(11):3313-8. PubMed ID: 22608396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.
    Saha A; Peck KK; Lis E; Holodny AI; Yamada Y; Karimi S
    Spine (Phila Pa 1976); 2014 Nov; 39(24):E1433-40. PubMed ID: 25188594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is dynamic contrast-enhanced MRI useful for assessing proximal fragment vascularity in scaphoid fracture delayed and non-union?
    Ng AW; Griffith JF; Taljanovic MS; Li A; Tse WL; Ho PC
    Skeletal Radiol; 2013 Jul; 42(7):983-92. PubMed ID: 23653220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of preoperative transarterial embolization in spinal tumors. A large single-center experience.
    Thiex R; Harris MB; Sides C; Bono CM; Frerichs KU
    Spine J; 2013 Feb; 13(2):141-9. PubMed ID: 23218826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer.
    Tuncbilek N; Kaplan M; Altaner S; Atakan IH; Süt N; Inci O; Demir MK
    AJR Am J Roentgenol; 2009 Apr; 192(4):949-55. PubMed ID: 19304699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.
    Jensen RL; Mumert ML; Gillespie DL; Kinney AY; Schabel MC; Salzman KL
    Neuro Oncol; 2014 Jan; 16(2):280-91. PubMed ID: 24305704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion parameters analysis of the vertebral bone marrow in patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic contrast-enhanced MRI (DCE-MRI) study.
    Courcoutsakis N; Spanoudaki A; Maris TG; Astrinakis E; Spanoudakis E; Tsatalas C; Prassopoulos P
    J Magn Reson Imaging; 2012 Mar; 35(3):696-702. PubMed ID: 22069235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI for oncology drug development.
    Sung YS; Park B; Choi Y; Lim HS; Woo DC; Kim KW; Kim JK
    J Magn Reson Imaging; 2016 Aug; 44(2):251-64. PubMed ID: 26854494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.